Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.99
-0.3148-0.76%
Post-market: 40.990.00000.00%16:10 EDT
Volume:44.88K
Turnover:1.84M
Market Cap:204.13M
PE:- -
High:41.42
Open:41.36
Low:40.84
Close:41.30
52wk High:47.00
52wk Low:29.28
Shares:4.98M
Float Shares:4.98M
Volume Ratio:1.33
T/O Rate:0.90%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application

TIPRANKS
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

Legend Biotech Corporation - Alan Bash to Resume Role as President, Carvykti

THOMSON REUTERS
·
Sep 15

Legend Biotech Corporation - Appoints Ingrid Zhang as CEO Effective September 15, 2026

THOMSON REUTERS
·
Sep 15

Cogent Biosciences, - FDA States no Advisory Committee Planned and no Review Issues Identified

THOMSON REUTERS
·
Sep 15

Cogent Biosciences Announces FDA Acceptance of New Drug Application (Nda) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (Advsm)

THOMSON REUTERS
·
Sep 15

Cogent Biosciences, - FDA Accepts Nda for Bezuclastinib in Advsm with Pdufa Date June 29, 2027

THOMSON REUTERS
·
Sep 15

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Sep 15

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Sep 15

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Sep 15

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Sep 15

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Sep 15

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 15

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Sep 15

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA

TIPRANKS
·
Sep 15

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for Rasonque™ (Daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Sep 15

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Sep 15